TLR4 engagement during TLR3-induced proinflammatory signaling in dendritic cells promotes IL-10-mediated suppression of antitumor immunity.
about
Building on sipuleucel-T for immunologic treatment of castration-resistant prostate cancer.Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cellsAutologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapyEffects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission.Growth, metastasis, and expression of CCL2 and CCL5 by murine mammary carcinomas are dependent upon Myd88.Soluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection.Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates.Plasma factors during chronic HIV-1 infection impair IL-12 secretion by myeloid dendritic cells via a virus-independent pathway.Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancerVaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccination.TLR4-mediated immunomodulatory properties of the bacterial metalloprotease arazyme in preclinical tumor modelsDifferential ability of surface and endosomal TLRs to induce CD8 T cell responses in vivoImmunotherapy for metastatic melanoma.Toll-like receptor agonists: current status and future perspective on their utility as adjuvants in improving anticancer vaccination strategies.Dendritic cell dysregulation during HIV-1 infection.Impact of MAPK Pathway Activation in BRAF(V600) Melanoma on T Cell and Dendritic Cell Function.Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.The role of dendritic cells in cancer.Inhibition of both BRAF and MEK in BRAF(V600E) mutant melanoma restores compromised dendritic cell (DC) function while having differential direct effects on DC properties.Altered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization.Preparation of tumor antigen-loaded mature dendritic cells for immunotherapy.Systemic cancer immunotherapy with Toll-like receptor 7 agonists: Timing is everything.Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition.Cancer immunotherapy: dendritic-cell vaccines on the move.Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10
P2860
Q34321844-6F8A0BE2-6D69-4FBB-8265-2859E1304DD5Q34735203-86C715F5-C9F0-479A-81B8-9A0BB2E564E8Q34749218-E3898145-495B-4514-A2D6-1A915985BD13Q35240847-E94AFF1D-100F-499F-89EC-D5194705B582Q35629284-9201773B-2A90-4235-9121-DEBD37A2D4FCQ35772650-0F3FB75A-771B-46C7-ADA1-E6C7BE064788Q35849215-B021B322-FF30-4AFA-84E8-58754F1543B4Q36427991-2F295A7D-4E38-4693-888B-22CDD48F1A67Q36632306-BEEAC95C-35A9-48E9-93A0-558DF8EAE287Q36710936-18849B11-EE6C-45B6-AE7D-921F3FFD9318Q37222202-F22A0CAC-3074-41F8-A48D-978158E2C744Q37728326-FA3CBF19-30DF-4B08-A14B-FEF433CFCBB7Q37946772-DB38257B-671F-4322-94C9-4E45A5C637D9Q38103581-0C0F1B4D-F4A7-4ACF-AD9E-751B1FCD9683Q38114911-4EAC970F-5302-4889-9BA6-74B9576DEDFCQ38160220-EB6472B0-8BC2-418B-974B-338CFF4AA905Q38776860-3B614FEB-07B9-4FDA-BC5A-EEF09F28B582Q38957065-D8702694-3894-43EA-8390-BF81535D0795Q39212742-9C20D271-10E8-41EF-9467-6EE78A510E0EQ39733403-71FF146C-2258-4209-A7C1-AF04E259C97CQ41855097-564C0500-E4F8-444C-B47B-AAE8A98F350EQ41954343-609ECD18-6C01-497E-8F1E-06E9939A69A2Q42321642-B0466014-2288-43AC-95B1-0B1EA0E5AD2FQ52959842-EAAB6FB8-3862-4BD7-954B-E610CC81BB72Q58767527-3795D9D6-8994-4E20-AD2A-6D2F4A8EC8EC
P2860
TLR4 engagement during TLR3-induced proinflammatory signaling in dendritic cells promotes IL-10-mediated suppression of antitumor immunity.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
TLR4 engagement during TLR3-in ...... ression of antitumor immunity.
@en
type
label
TLR4 engagement during TLR3-in ...... ression of antitumor immunity.
@en
prefLabel
TLR4 engagement during TLR3-in ...... ression of antitumor immunity.
@en
P2093
P2860
P1433
P1476
TLR4 engagement during TLR3-in ...... ression of antitumor immunity.
@en
P2093
Alice Yewdall
Andres M Salazar
Anne Gallois
Dusan Bogunovic
Emmanuelle Godefroy
Isabelle Marie
Nina Bhardwaj
Olivier Manches
P2860
P304
P356
10.1158/0008-5472.CAN-10-3988
P407
P50
P577
2011-07-05T00:00:00Z